Increased replication of HIV-1 minor variants during hematopoietic stem-cell mobilization with filgrastim

Journal of Infectious Diseases

Volumn 190, Issue 2, 2004, Pages 257-266

  Campbell, Thomas B ^a,d   Rapaport, Eric ^a   Schooley, Robert T ^a   Kuritzkes, Daniel B ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VIRUS RNA;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; SPECIES; STEM CELL MOBILIZATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; DRUG RESISTANCE, VIRAL; FILGRASTIM; GENES, ENV; GENOTYPE; HEMATOPOIETIC STEM CELL MOBILIZATION; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; PEPTIDE FRAGMENTS; PHYLOGENY; RECEPTORS, CCR5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VARIATION (GENETICS); VIREMIA;

EID: 3242710136     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/421122     Document Type: Article

References (29)

1. Meyerhans A, Cheynier R, Albert J, et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989; 58:901-10.
2. Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr 1989; 2:344-52.
3. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271:1582-6.
4. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995; 267:483-9.
5. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362:355-8.
6. Korber B, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68:7467-81.
7. Ping H, Cohen MS, Hoffman I, et al. Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol 2000; 74:8946-52.
8. Ostrowski MA, Krakauer DC, Li Y, et al. Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J Virol 1998; 72:7772-7784.
9. Kovacs JA, Imamichi H, Vogel S, et al. Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus and quasi-species expression. J Infect Dis 2000; 182:1063-9.
10. Schooley RT, Mladenovic J, Sevin A, et al. Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease. J Infect Dis 2000; 181:148-57.
11. Campbell TB, Sevin A, Coombs RW, et al. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Blood 2000; 95:48-55.
12. Gunthard HF, Frost SDW, Leigh-Brown AJ, et al. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol 1999; 73: 9404-12.
13. Kuritzkes DR, Grant RM, Feorino P, et al. Performance characteristics of the TRUEGENE HIV-1 Genotyping Kit and OpenGene DNA Sequencing System. J Clin Microbiol 2003; 41:1594-9.
14. Schooley RT, Campbell TB, Kuritzkes DR, et al. A phase 1 study of combination therapy with L-697,661 and zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:363-70.
15. Kuiken C, Korber B. Sequence quality control. In: Human retroviruses and AIDS. Korber B, Kuiken C, Foley B, et al. eds. Los Alamos, NM: Los Alamos National Laboratory, 1998:80-90.
16. Chesebro B, Wehrly K, Nishio J, Perryman S. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J Virol 1996; 70:9055-9.
17. Xiao L, Owen SM, Goldman I, et al. CCR5 coreceptor usage of non-syncytium-inducing primay HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 1998; 240:83-92.
18. Hung C-S, Vander Heyden N, Ratner L. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J Virol 1999; 73:8216-26.
19. Koyangi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen ISY. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988; 241:1673-5.
20. Perno CF, Cooney DA, Gao W-Y, et al. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/ macrophages. Blood 1992; 80:995-1003.
21. Morikawa K, Morikawa S, Nakamura M, Miyawaki T. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br J Haematol 2002; 118:296-304.
22. Lee KY, Suh B-G, Kim JW, et al. Varying expression levels of colony stimulating factor receptors in disease states and different leukocytes. Exp Mol Med 2000; 32:210-5.
23. Geissler K, Harrington M, Srivastava C, Leemhuis T, Tricot G, Broxmeyer HE. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation. J Immunol 1989; 143: 140-6.
24. Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 2000; 95:270-6.
25. Sloand EM, Kim S, Maciejewski JP, et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000; 95:2269-74.
26. Saito M, Kiyokawa N, Taguchi T, et al. Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion. Exp Hematol 2002; 30:1115-23.
27. Franzke A, Piao W, Lauber J, et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and auto immune disease. Blood 2003; 102:734-9.
28. Hartung T, Pitrak DL, Foote M, Shatzen EM, Verral SC, Wendel A. Filgrastim restores interleukin-2 production in blood from patients with advanced human immunodeficiency virus infection. J Infect Dis 1998; 178:686-92.
29. Baillou C, Simon A, Leclercq V, et al. Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy. AIDS 2003; 17:563-74.